تقرير
Hypersensitivity to nabumetone: cross reactivity with naproxen.
العنوان: | Hypersensitivity to nabumetone: cross reactivity with naproxen. |
---|---|
المؤلفون: | Perez-Ezquerra PR, Sanchez-Morillas L, Laguna Martinez JJ, Gonzalez Mendiola R, Gomez-Traseira C, Carrasco Garcia I, Herranz Mañas M, Rubio Matos A |
المصدر: | Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2013 Jul; Vol. 111 (1), pp. 74-5. |
نوع المنشور: | Case Reports; Letter |
اللغة: | English |
بيانات الدورية: | Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann Allergy Asthma Immunol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: McLean, VA : American College of Allergy, Asthma, and Immunology |
مواضيع طبية MeSH: | Butanones/*adverse effects , Butanones/*immunology , Cyclooxygenase 2 Inhibitors/*adverse effects , Cyclooxygenase 2 Inhibitors/*immunology , Drug Hypersensitivity/*immunology , Naproxen/*immunology, Adult ; Angioedema/etiology ; Butanones/therapeutic use ; Cross Reactions ; Cyclooxygenase Inhibitors/adverse effects ; Cyclooxygenase Inhibitors/immunology ; Cyclooxygenase Inhibitors/therapeutic use ; Female ; Humans ; Middle Aged ; Nabumetone ; Naproxen/adverse effects ; Naproxen/therapeutic use ; Urticaria/etiology |
المشرفين على المادة: | 0 (Butanones) 0 (Cyclooxygenase 2 Inhibitors) 0 (Cyclooxygenase Inhibitors) 57Y76R9ATQ (Naproxen) LW0TIW155Z (Nabumetone) |
تواريخ الأحداث: | Date Created: 20130629 Date Completed: 20130903 Latest Revision: 20181203 |
رمز التحديث: | 20240628 |
DOI: | 10.1016/j.anai.2013.05.006 |
PMID: | 23806470 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1534-4436 |
---|---|
DOI: | 10.1016/j.anai.2013.05.006 |